Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To Carl Johnson
Brian:
PDS doesn't own MMP unless something changed. MMP is owned 50/50 by TPL and PTSC. PDS is the licensing authority, isn't it?


I challenge the BoD of PTSC to make available, upon request by a shareholder, a copy of the Agenda and Minutes of the PTSC Board meeting at which it was agreed by a 3-0 or 2-1 vote of the Board of Directors to direct PTSC's representative at PDS (Carlton Johnson) to accept the agreement with Aliacense. Maybe a flood of emails to ir@ptsc.com would get them to take the hint.
Share
New Message
Please login to post a reply